GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Mar SA (OTCPK:PHMMF) » Definitions » Cyclically Adjusted PB Ratio

Pharma Mar (Pharma Mar) Cyclically Adjusted PB Ratio : 5.14 (As of Jun. 16, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Pharma Mar Cyclically Adjusted PB Ratio?

As of today (2024-06-16), Pharma Mar's current share price is $31.15. Pharma Mar's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $6.06. Pharma Mar's Cyclically Adjusted PB Ratio for today is 5.14.

The historical rank and industry rank for Pharma Mar's Cyclically Adjusted PB Ratio or its related term are showing as below:

PHMMF' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 3.9   Med: 11.88   Max: 49.07
Current: 5.89

During the past years, Pharma Mar's highest Cyclically Adjusted PB Ratio was 49.07. The lowest was 3.90. And the median was 11.88.

PHMMF's Cyclically Adjusted PB Ratio is ranked worse than
82.7% of 659 companies
in the Biotechnology industry
Industry Median: 1.73 vs PHMMF: 5.89

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Pharma Mar's adjusted book value per share data for the three months ended in Mar. 2024 was $11.962. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $6.06 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Pharma Mar Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Pharma Mar's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Mar Cyclically Adjusted PB Ratio Chart

Pharma Mar Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.74 24.89 15.56 13.47 7.18

Pharma Mar Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.78 5.76 5.80 7.18 4.83

Competitive Comparison of Pharma Mar's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Pharma Mar's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharma Mar's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharma Mar's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Pharma Mar's Cyclically Adjusted PB Ratio falls into.



Pharma Mar Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Pharma Mar's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=31.15/6.06
=5.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharma Mar's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Pharma Mar's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=11.962/122.7621*122.7621
=11.962

Current CPI (Mar. 2024) = 122.7621.

Pharma Mar Quarterly Data

Book Value per Share CPI Adj_Book
201406 5.103 101.081 6.198
201409 4.909 100.441 6.000
201412 4.312 100.251 5.280
201503 4.144 99.474 5.114
201506 4.691 101.138 5.694
201509 4.960 99.559 6.116
201512 4.541 100.268 5.560
201603 4.185 98.638 5.209
201606 3.807 100.333 4.658
201609 3.655 99.737 4.499
201612 2.999 101.842 3.615
201703 2.902 100.896 3.531
201706 2.874 101.848 3.464
201709 2.533 101.524 3.063
201712 1.724 102.975 2.055
201803 1.708 102.122 2.053
201806 1.902 104.165 2.242
201809 2.034 103.818 2.405
201812 1.319 104.193 1.554
201903 0.698 103.488 0.828
201906 0.008 104.612 0.009
201909 -0.316 103.905 -0.373
201912 0.683 105.015 0.798
202003 4.860 103.469 5.766
202006 6.585 104.254 7.754
202009 6.367 103.521 7.550
202012 6.899 104.456 8.108
202103 8.364 104.857 9.792
202106 8.952 107.102 10.261
202109 9.354 107.669 10.665
202112 11.162 111.298 12.312
202203 12.340 115.153 13.155
202206 12.091 118.044 12.574
202209 11.630 117.221 12.180
202212 13.043 117.650 13.610
202303 12.924 118.948 13.338
202306 12.674 120.278 12.936
202309 12.368 121.343 12.513
202312 11.959 121.300 12.103
202403 11.962 122.762 11.962

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Pharma Mar  (OTCPK:PHMMF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Pharma Mar Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Pharma Mar's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharma Mar (Pharma Mar) Business Description

Industry
Traded in Other Exchanges
Address
Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770
Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and market insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology, Diagnostics, Consumer chemicals, and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.

Pharma Mar (Pharma Mar) Headlines

From GuruFocus